BRR OpCo’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

BRR OpCo’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-40,000	Closed	-$2K	–	173
2018 Q4	$2K	Hold	40,000	–	–	﹤0.01%	108
2018 Q3	$3K	Hold	40,000	–	–	﹤0.01%	112
2018 Q2	$3K	Hold	40,000	–	–	﹤0.01%	111
2018 Q1	$2K	Hold	40,000	–	–	﹤0.01%	107
2017 Q4	$3K	Buy	+40,000	New	+$3K	﹤0.01%	102

Other funds holding PVCT

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

ACM

Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return

LIA

LBMC Investment Advisors Brentwood, Tennessee $1.64B AUM 15.26% 1-Year Est. Return

QCIG

Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return

BRR OpCo's PVCT Position: Q1 2019 in Review

BRR OpCo sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q1 2019, closing a stake of 40,000 shares — an estimated $2K sold.

BRR OpCo first reported a position in PVCT in Q4 2017 and held it in 5 quarters. The position peaked at $3K in Q3 2018. 4 funds tracked by Wall St. Rank hold PVCT as of Q1 2019.

BRR OpCo reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q1 2019 after selling out during the quarter.
BRR OpCo sold 40,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q1 2019, an estimated $2K.
BRR OpCo first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2017 and held it in 5 quarters.
BRR OpCo's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $3K in Q3 2018.
4 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q1 2019.

Based on BRR OpCo's 13F filing for Q1 2019, filed 26 Apr 2019.